Nicola Fazio (N Fazio)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Topics

Neuroendocrine Tumors

Ejection Fraction

Top Venues

Journal of endocrinological investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Spada, Massimo Milione, Patrick Maisonneuve, Natalie Prinzi, Valeria Smiroldo, Elena Bolzacchini, Sara Pusceddu, Carlo Carnaghi, Fausto Sessa, Stefano La Rosa, Silvia Uccella, Nicola Fazio
An Italian real-world multicenter study of patients with advanced mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) of the gastro-entero-pancreatic system treated with chemotherapy. Journal of endocrinological investigation 47 (9) (2024)
Francesca Spada, Massimo Milione, Patrick Maisonneuve, Natalie Prinzi, Valeria Smiroldo, Elena Bolzacchini, Sara Pusceddu, Carlo Carnaghi, Fausto Sessa, Stefano La Rosa, Silvia Uccella, Nicola Fazio
An Italian real-world multicenter study of patients with advanced mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) of the gastro-entero-pancreatic system treated with chemotherapy. Journal of endocrinological investigation (2024)
Francesca Spada, Massimo Milione, Patrick Maisonneuve, Natalie Prinzi, Valeria Smiroldo, Elena Bolzacchini, Sara Pusceddu, Carlo Carnaghi, Fausto Sessa, Stefano La Rosa, Silvia Uccella, Nicola Fazio
An Italian real-world multicenter study of patients with advanced mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) of the gastro-entero-pancreatic system treated with chemotherapy. Journal of endocrinological investigation 47 (9) (2024)
Alice Laffi, Lorenzo Gervaso, Oriana D'Ecclesiis, Sara Gandini, Agostino Riva, Rita Passerini, Francesca Spada, Stefania Pellicori, Manila Rubino, Chiara Alessandra Cella, Paola Simona Ravenda, Maria Giulia Zampino, Nicola Fazio
Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE). Biomedicines 11 (2) (2023)
Mariarosaria Calvello, Monica Marabelli, Sara Gandini, Elena Marino, Loris Bernard, Matteo Dal Molin, Giulia Di Cola, Cristina Zanzottera, Giovanni Corso, Nicola Fazio, Lorenzo Gervaso, Uberto Fumagalli Romario, Massimo Barberis, Aliana Guerrieri-Gonzaga, Lucio Bertario, Davide Serrano, Bernardo Bonanni
Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience. Genes 14 (5) (2023)
Samuel J Klempner, Keun-Wook Lee, Kohei Shitara, Jean-Phillippe Metges, Sara Lonardi, David H Ilson, Nicola Fazio, Tae-Yong Kim, Li-Yuan Bai, Diarmuid Moran, Jianning Yang, Ahsan Arozullah, Jung Wook Park, Jeffrey J Raizer, Yung-Jue Bang, Manish A Shah
ILUSTRO: Phase 2 Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Davide Ciardiello, Stefania Napolitano, Vincenzo Famiglietti, Lucia Esposito, Vincenzo De Falco, Alessandra Di Liello, Antonio Avallone, Evaristo Maiello, Filippo Pietrantonio, Chiara Cremolini, Maria Giulia Zampino, Nicola Fazio, Teresa Troiani, Erika Martinelli, Fortunato Ciardiello, Giulia Martini
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials. Cancers 15 (7) (2023)
Chiara Alessandra Cella, Riccardo Cazzoli, Nicola Fazio, Giuseppina De Petro, Germano Gaudenzi, Silvia Carra, Mauro Romanenghi, Francesca Spada, Ilaria Grossi, Isabella Pallavicini, Saverio Minucci, Giovanna Mantovani
Cabozantinib in neuroendocrine tumors: tackling drug activity and resistance mechanisms. Endocrine-related cancer 30 (12) (2023)
Nicola Fazio, Massimo Falconi, Emanuela Foglia, Mirco Bartolomei, Alfredo Berruti, Mirko D'Onofrio, Diego Ferone, Alessandro Giordano, Franco Grimaldi, Massimo Milione, Francesco Panzuto, Monica Santimaria, Orazio Schillaci, Ettore Seregni, Michele Stasi, Marco Volante, Secondo Lastoria
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group. Advances in therapy (2023)
Alice Laffi, Lorenzo Gervaso, Oriana D'Ecclesiis, Sara Gandini, Agostino Riva, Rita Passerini, Francesca Spada, Stefania Pellicori, Manila Rubino, Chiara Alessandra Cella, Paola Simona Ravenda, Maria Giulia Zampino, Nicola Fazio
Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE). Biomedicines 11 (2) (2023)
Mirco Bartolomei, Alfredo Berruti, Massimo Falconi, Nicola Fazio, Diego Ferone, Secondo Lastoria, Giovanni Luigi Pappagallo, Ettore Seregni, Annibale Versari
Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise. Cancers 14 (10) (2022)
Nicola Fazio, Patrick Maisonneuve, Francesca Spada, Lorenzo Gervaso, Chiara Alessandra Cella, Marta Pozzari, Dario Zerini, Eleonora Pisa, Caterina Fumagalli, Massimo Barberis, Alice Laffi, Chiara Maria Grana C, Gianmarco Orsolini, Pierpaolo Prestianni, Guido Bonomo, Luigi Funicelli, Emilio Bertani, Paola Queirolo, Davide Ravizza, Manila Rubino, Giulio Tosti, Elisabetta Pennacchioli
Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series. Cancers 14 (19) (2022)
Marie-Louise F Van Velthuysen, Anne Couvelard, Guido Rindi, Nicola Fazio, Dieter Hörsch, Elisabeth J M Nieveen van Dijkum, Günter Klöppel, Aurel Perren
ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology. Journal of neuroendocrinology 34 (3) (2022)
Xiaoyang Lan, Nicola Fazio, Omar Abdel-Rahman
Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms. Metabolites 12 (11) (2022)
Giulia Arrivi, Francesca Spada, Samuele Frassoni, Vincenzo Bagnardi, Alice Laffi, Manila Rubino, Lorenzo Gervaso, Nicola Fazio
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysis. Journal of neuroendocrinology 34 (10) (2022)
Chiara Alessandra Cella, Francesca Spada, Alfredo Berruti, Francesco Bertolini, Patrizia Mancuso, Massimo Barberis, Eleonora Pisa, Manila Rubino, Lorenzo Gervaso, Alice Laffi, Stefania Pellicori, Davide Radice, Laura Zorzino, Angelica Calleri, Luigi Funicelli, Giuseppe Petralia, Nicola Fazio
Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes. Cancers 14 (18) (2022)
Jaume Capdevila, Nicola Fazio, Carlos Lopez, Alexandre Teulé, Juan W Valle, Salvatore Tafuto, Ana Custodio, Nicholas Reed, Markus Raderer, Enrique Grande, Rocio Garcia-Carbonero, Paula Jiménez-Fonseca, Jorge Hernando, Alberto Bongiovanni, Francesca Spada, Vicente Alonso, Lorenzo Antonuzzo, Andrea Spallanzani, Alfredo Berruti, Adelaida La Casta, Isabel Sevilla, Patrizia Kump, Dario Giuffrida, Xavier Merino, Lorena Trejo, Pablo Gajate, Ignacio Matos, Angela Lamarca, Toni Ibrahim
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (20) (2021)
G Vivanet, Lorenzo Gervaso, A Laffi, M Rubino, F Spada, Nicola Fazio
Ten years-experience of sunitinib in the treatment of advanced pan-NETs: an update on safety profile. Expert opinion on drug safety (2021)
Nicola Fazio, Carlo Carnaghi, Roberto Buzzoni, Juan W Valle, Fabian Herbst, Antonia Ridolfi, Jonathan Strosberg, Matthew H Kulke, Marianne E Pavel, James C Yao
Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trials. Cancer 127 (15) (2021)
Francesca Spada, Roberta E Rossi, Elda Kara, Alice Laffi, Sara Massironi, Manila Rubino, Franco Grimaldi, Sherrie Bhoori, Nicola Fazio
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Alice Laffi, Marzia Colandrea, Giuseppe Buonsanti, Samuele Frassoni, Vincenzo Bagnardi, Francesca Spada, Eleonora Pisa, Massimo Barberis, Manila Rubino, Chiara Maria Grana, Francesco Ceci, Nicola Fazio
A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3). Diagnostics (Basel, Switzerland) 11 (12) (2021)
Jasminka Hasic Telalovic, Serena Pillozzi, Rachele Fabbri, Alice Laffi, Daniele Lavacchi, Virginia Rossi, Lorenzo Dreoni, Francesca Spada, Nicola Fazio, Amedeo Amedei, Ernesto Iadanza, Lorenzo Antonuzzo
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy. Diagnostics (Basel, Switzerland) 11 (5) (2021)
Nicola Fazio, Omar Abdel-Rahman
Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now? Current treatment options in oncology 22 (3) (2021)
Massimo Falconi, Nicola Fazio, Diego Ferone, Annibale Versari
Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi survey. Expert opinion on pharmacotherapy 21 (18) (2020)
Marta Peri, Nicola Fazio
Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature. Lung Cancer (Auckland, N.Z.) 11 (2020)
Nicola Fazio
Personalizing Multimodal Treatment in Patients With Pancreatic Neuroendocrine Tumors. JCO oncology practice 16 (11) (2020)
Francesca Spada, Patrick Maisonneuve, Caterina Fumagalli, Riccardo Marconcini, Fabio Gelsomino, Lorenzo Antonuzzo, Davide Campana, Ivana Puliafito, Giulio Rossi, Pinuccia Faviana, Luca Messerini, Massimo Barberis, Nicola Fazio
Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis. Endocrine 72 (1) (2020)
F Spada, S Pellicori, G Zampino, L Funicelli, L Gervaso, A Laffi, M Rubino, R Garcia-Carbonero, Nicola Fazio
SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view. Endocrine 70 (1) (2020)
Diana Martins, Francesca Spada, Ioana Lambrescu, Manila Rubino, Chiara Cella, Bianca Gibelli, Chiara Grana, Dario Ribero, Emilio Bertani, Davide Ravizza, Guido Bonomo, Luigi Funicelli, Eleonora Pisa, Dario Zerini, Nicola Fazio, null null
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors. Targeted oncology 12 (5) (2018)
Nicola Fazio, Roberto Buzzoni, Gianfranco Delle Fave, Margot E Tesselaar, Edward Wolin, Eric Van Cutsem, Paola Tomassetti, Jonathan Strosberg, Maurizio Voi, Lida Bubuteishvili-Pacaud, Antonia Ridolfi, Fabian Herbst, Jiri Tomasek, Simron Singh, Marianne Pavel, Matthew H Kulke, Juan W Valle, James C Yao
Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis. Cancer science 109 (1) (2017)